☆ 4.3 Letter

Primary Progressive Aphasia has a Unique Signature Distinct from Dementia of the Alzheimer's Type and Behavioral Variant Frontotemporal Dementia Regardless of Pathology

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Journal

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Volume 79, Issue 12, Pages 1379-1381

Publisher

OXFORD UNIV PRESS INC

DOI: 10.1093/jnen/nlaa080

Keywords

-

Categories

Clinical Neurology Neurosciences Pathology

Funding

NIA/NIH [P30 AG013854, R01 NS085770, R01 NS075075, R01 AG056258, R01 AG062566]
NIDCD/NIH [R01 DC008552]
NACC New Investigator Award [U01 AG016976]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Clinical Neurology

Automated Detection of Speech Timing Alterations in Autopsy-Confirmed Nonfluent/Agrammatic Variant Primary Progressive Aphasia

Adolfo M. Garcia, Ariane E. Welch, Maria Luisa Mandelli, Maya L. Henry, Sladjana Lukic, Maria Jose Torres Prioris, Jessica Deleon, Buddhika M. Ratnasiri, Diego L. Lorca-Puls, Bruce L. Miller, William Seeley, Adam P. Vogel, Maria Luisa Gorno-Tempini

Summary: This study utilized automated speech timing analyses in a cohort of autopsy-proven cases to investigate motor speech function in individuals with nfvPPA. The results indicated that automated analysis can capture specific markers of nfvPPA and potentially discriminate between patients with different tauopathies. The objectivity and scalability of this approach could support standard speech assessments.

NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Automated Detection of Speech Timing Alterations in Autopsy-Confirmed Nonfluent/Agrammatic Variant Primary Progressive Aphasia

Adolfo M. Garcia, Ariane E. Welch, Maria Luisa Mandelli, Maya L. Henry, Sladjana Lukic, Maria Jose Torres Prioris, Jessica Deleon, Buddhika M. Ratnasiri, Diego L. Lorca-Puls, Bruce L. Miller, William Seeley, Adam P. Vogel, Maria Luisa Gorno-Tempini

Summary: Automated speech timing analyses can identify specific markers of nfvPPA and potentially differentiate between patients with different tauopathies. This approach, thanks to its objectivity and scalability, could be a valuable support for standard speech assessments.

NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Semantic variant primary progressive aphasia with a pathogenic variant p.Asp40Gly in the ANXA11 gene

Eun-Joo Kim, So Young Moon, Hee-Jin Kim, Na-Yeon Jung, Sun Min Lee, Young Eun Kim

Summary: We present a case of right-predominant semantic variant primary progressive aphasia in a patient with the p.Asp40Gly variant of ANXA11. This is the first report of frontotemporal dementia without clinical and electrophysiological evidence of amyotrophic lateral sclerosis associated with a known pathogenic variant of ANXA11.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Completed Suicide by Firearm in an Individual With the Agrammatic Variant of Primary Progressive Aphasia: Case Report

Deepal Patel, Shaun Andersen, Kyler Smith, Aaron Ritter

Summary: The nonfluent variant of Primary Progressive Aphasia (nfvPPA) is a form of Frontotemporal Dementia characterized by progressive language dysfunction. This article presents a case of completed suicide in a patient with nfvPPA, who showed increasing irritability and impulsivity along with a decline in language and motoric functioning. The suicide came as a shock to his spouse, family, and clinical care team, as there is limited understanding of suicide risk in this patient population.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

The natural history of primary progressive aphasia: beyond aphasia

Hulya Ulugut, Simone Stek, Lianne E. E. Wagemans, Roos J. Jutten, Maria Antoinette Keulen, Femke H. Bouwman, Niels D. Prins, Afina W. Lemstra, Welmoed Krudop, Charlotte E. Teunissen, Bart N. M. van Berckel, Rik Ossenkoppele, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Yolande A. L. Pijnenburg

Summary: Primary progressive aphasia (PPA) is divided into three prototypical subtypes - semantic, non-fluent, and logopenic - each subtype progresses differently over time and has a relatively long disease duration.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Primary progressive aphasia: six questions in search of an answer

Christopher R. S. Belder, Charles R. Marshall, Jessica Jiang, Salvatore Mazzeo, Anthipa Chokesuwattanaskul, Jonathan D. Rohrer, Anna Volkmer, Chris J. D. Hardy, Jason D. Warren

Summary: This article reviews recent progress in the diagnosis and management of primary progressive aphasia, the language-led dementias. It poses six key unanswered questions and suggests that linking proteinopathies to phenotypes may help resolve the clinical complexity of this disease.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Immunology

Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation

Aitana Sogorb-Esteve, Imogen J. Swift, Ione O. C. Woollacott, Jason D. Warren, Henrik Zetterberg, Jonathan D. Rohrer

Summary: This study investigated the role of chemokines in primary progressive aphasias, revealing differential alterations in cerebrospinal fluid (CSF) and plasma across the PPA variants. The results suggest a potential role for neuroinflammation in these poorly understood sporadic disorders, indicating a potential therapeutic target for the future.

JOURNAL OF NEUROINFLAMMATION (2021)

Add to Collection

Article Neurosciences

A novel GRN mutation in an Italian patient with non-fluent variant of primary progressive aphasia at onset: a longitudinal case report

Veronica Castelnovo, Elisa Canu, Teuta Domi, Laura Pozzi, Francesca Vignaroli, Edoardo Gioele Spinelli, Alma Ghirelli, Giacomo Tondo, Cristoforo Comi, Nilo Riva, Angelo Quattrini, Paola Carrera, Massimo Filippi, Federica Agosta

Summary: We report a case with a novel Progranulin gene (GRN) mutation and non-fluent language disturbances at onset. The patient presented with prominent language production difficulties and showed left fronto-temporal and striatal alterations on imaging. Genetic analysis revealed a new GRN mutation. The findings expand our understanding of phenotypic heterogeneity in GRN mutation carriers.

FRONTIERS IN NEUROSCIENCE (2023)

Add to Collection

Article Clinical Neurology

Functional decline in the aphasic variant of Alzheimer's disease

Stacey Moeller, Jaiashre Sridhar, Adam Martersteck, Christina Coventry, Alan Kuang, Hui Zhang, Sandra Weintraub, M. -Marsel Mesulam, Emily Rogalski

Summary: The study found that individuals with non-semantic PPA suspected to have AD showed more pronounced functional decline in daily activities compared to those with non-AD neuropathology.

ALZHEIMERS & DEMENTIA (2021)

Add to Collection

Article Clinical Neurology

Primary Progressive Aphasia Associated With GRN Mutations New Insights Into the Nonamyloid Logopenic Variant

Dario Saracino, Sophie Ferrieux, Marie Nogues-Lassiaille, Marion Houot, Aurelie Funkiewiez, Leila Sellami, Vincent Deramecourt, Florence Pasquier, Philippe Couratier, Jeremie Pariente, Amandine Geraudie, Stephane Epelbaum, David Wallon, Didier Hannequin, Olivier Martinaud, Fabienne Clot, Agnes Camuzat, Simona Bottani, Daisy Rinaldi, Sophie Auriacombe, Marie Sarazin, Mira Didic, Claire Boutoleau-Bretonniere, Christel Thauvin-Robinet, Julien Lagarde, Carole Roue-Jagot, Francois Sellal, Audrey Gabelle, Frederique Etcharry-Bouyx, Alexandre Morin, Cinzia Coppola, Richard Levy, Bruno Dubois, Alexis Brice, Olivier Colliot, Maria Luisa Gorno-Tempini, Marc Teichmann, Raffaella Migliaccio, Isabelle Le Ber

Summary: This study revealed that nonamyloid lvPPA is the most frequent variant associated with GRN mutations, followed by nfvPPA and mixed forms, showing that the language network may be affected at different levels. GRN testing is crucial for both familial and sporadic PPA patients, suggesting implications for future GRN gene-specific therapies.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

A Spanish Neuropsychological Battery Discriminates Between the Behavioral Variant of Frontotemporal Dementia and Primary Progressive Aphasia in a Colombian Sample

Lina Velilla, Jonathan Hernandez, Margarita Giraldo-Chica, Edmarie Guzman-Velez, Yakeel Quiroz, Francisco Lopera

Summary: The study aimed to differentiate between different FTD variants, finding that bvFTD patients performed worse in executive function tests, while PPA patients showed lower performances in language tests and MMSE global scores. After running the linear discriminant model, it was discovered that specific combinations of cognitive tests and subtests, as well as functions composed of MoCA language subtests and performance errors, were better at predicting group belonging for bvFTD and PPA.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

SQSTM1 variant in disorders of the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous variant and a review of the literature

Weishuai Li, Han Gao, Xiaoyu Dong, Dongming Zheng

Summary: Mutations in the SQSTM1 gene may be associated with various clinical subtypes of frontotemporal dementia and amyotrophic lateral sclerosis, including the rare combination of PNFA and PBP. The main type of mutation is exon missense mutation, commonly found in the UBA domain.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Primary Progressive Aphasia: Toward a Pathophysiological Synthesis

Justina Ruksenaite, Anna Volkmer, Jessica Jiang, Jeremy C. S. Johnson, Charles R. Marshall, Jason D. Warren, Chris J. D. Hardy

Summary: This review focuses on the key issues related to the diagnosis, disease stage assessment, proteinopathy phenotyping, core auditory impairments, treatment challenges, and pathophysiological features of each major variant of primary progressive aphasia (PPA). The new findings elucidating the pathophysiology of PPA represent significant progress in understanding these diseases, with implications for diagnosis, care, management, and therapies.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)

Add to Collection

Article Behavioral Sciences

Primary progressive aphasias associated with C9orf72 expansions: Another side of the story

Dario Saracino, Amandine Geraudie, Anne M. Remes, Sophie Ferrieux, Marie Nogues-Lassiaille, Simona Bottani, Lorenzo Cipriano, Marion Houot, Aurelie Funkiewiez, Agnes Camuzat, Daisy Rinaldi, Marc Teichmann, Jeremie Pariente, Philippe Couratier, Claire Boutoleau-Bretonniere, Sophie Auriacombe, Frederique Etcharry-Bouyx, Richard Levy, Raffaella Migliaccio, Eino Solje, Isabelle Le Ber

Summary: This study comprehensively analyzed 16 patients with PPA-C9orf72, revealing linguistic deficits and patterns of grey-matter atrophy. In addition to the common non-fluent/agrammatic variant, semantic and mixed forms of PPA were also observed. The study highlights the role of C9orf72 mutation in disrupting the anterior parts of the language network and provides guidelines for genetic testing in PPA patients.

CORTEX (2021)

Add to Collection

Article Neurosciences

Semantic Variant Primary Progressive Aphasia: Practical Recommendations for Treatment from 20 Years of Behavioural Research

Aida Suarez-Gonzalez, Sharon A. Savage, Nathalie Bier, Maya L. Henry, Regina Jokel, Lyndsey Nickels, Cathleen Taylor-Rubin

Summary: The article provides an overview of interventions to support language in people with semantic variant primary progressive aphasia (svPPA) over the last two decades and offers recommendations for future clinical practice. It concludes that an integrative framework of treatment and care is the best practice for svPPA, combining rehabilitation interventions, compensatory approaches, education, and support within the context of dementia.

BRAIN SCIENCES (2021)

Add to Collection

Review Clinical Neurology

The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results

Alexander Z. Feldman, Lawrence J. Jennings, Nitin R. Wadhwani, Daniel J. Brat, Craig M. Horbinski

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)

Add to Collection

Article Pathology

YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas

Kathleen M. Schieffer, Vibhuti Agarwal, Stephanie LaHaye, Katherine E. Miller, Daniel C. Koboldt, Tara Lichtenberg, Kristen Leraas, Patrick Brennan, Benjamin J. Kelly, Erin Crist, Jerome Rusin, Jonathan L. Finlay, Diana S. Osorio, Eric A. Sribnick, Jeffrey R. Leonard, Alexander Feldman, Brent A. Orr, Jonathan Serrano, Varshini Vasudevaraja, Matija Snuderl, Peter White, Vincent Magrini, Richard K. Wilson, Elaine R. Mardis, Daniel R. Boue, Catherine E. Cottrell

Summary: Meningiomas, a type of central nervous system tumor, can be associated with the NF2 gene mutation. However, YAP1 fusion meningiomas have been found to exhibit distinct genetic and biological characteristics compared to NF2-driven meningiomas. Both types of meningiomas show overexpression of EGFR and MET, but YAP1 fusion meningiomas have unique histopathological features and a different DNA methylation profile.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Add to Collection

Article Neurosciences

Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance

Tamar Gefen, Allegra Kawles, Beth Makowski-Woidan, Janessa Engelmeyer, Ivan Ayala, Payam Abbassian, Hui Zhang, Sandra Weintraub, Margaret E. Flanagan, Qinwen Mao, Eileen H. Bigio, Emily Rogalski, M. Marsel Mesulam, Changiz Geula

Summary: The study revealed that Cognitive SuperAgers have significantly fewer NFTs in the entorhinal cortex compared to age-matched cognitively average normal controls, suggesting their resistance to age-related neurofibrillary degeneration could contribute to preserved memory.

CEREBRAL CORTEX (2021)

Add to Collection

Article Neurosciences

Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma

Kathleen M. Schieffer, Alexander Z. Feldman, Esko A. Kautto, Sean McGrath, Anthony R. Miller, Maria Elena Hernandez-Gonzalez, Stephanie LaHaye, Katherine E. Miller, Daniel C. Koboldt, Patrick Brennan, Benjamin Kelly, Amy Wetzel, Vibhuti Agarwal, Margaret Shatara, Suzanne Conley, Diana P. Rodriguez, Rolla Abu-Arja, Ala Shaikhkhalil, Matija Snuderl, Brent A. Orr, Jonathan L. Finlay, Diana S. Osorio, Annie I. Drapeau, Jeffrey R. Leonard, Christopher R. Pierson, Peter White, Vincent Magrini, Elaine R. Mardis, Richard K. Wilson, Catherine E. Cottrell, Daniel R. Boue

Summary: Retinoblastoma is a childhood cancer of the retina caused by germline or somatic alterations of the RB1 gene. Rare cases of retinoblastoma in the sellar-suprasellar region without ocular or pineal tumors have been documented. Molecular analysis, including DNA array-based methylation profiling and sequencing-based methodologies, was essential for classification and understanding the complex mechanism of RB1 inactivation in this challenging tumor.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance

Changiz Geula, Sara R. Dunlop, Ivan Ayala, Allegra S. Kawles, Margaret E. Flanagan, Tamar Gefen, Marek-Marsel Mesulam

Summary: Basal forebrain cholinergic neurons (BFCN) are crucial in cognitive processes and are differently affected by various neuropathologies that cause dementia. Different proteinopathies have distinct impacts on BFCN, leading to different vulnerabilities and resilience to neurodegenerative effects. Understanding these mechanisms is essential for therapeutic interventions.

JOURNAL OF NEUROCHEMISTRY (2021)

Add to Collection

Review Oncology

The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results

Lauren S. Singer, Alexander Z. Feldman, Robin A. Buerki, Craig M. Horbinski, Rimas Lukas, Roger Stupp

Summary: The recent update by WHO on central nervous system tumor classification has reshaped tumor identification and treatment options. The inclusion of molecular markers has necessitated a re-evaluation of pivotal trials and how to interpret them, as well as a focus on incorporating molecular markers into future trials.

CHINESE CLINICAL ONCOLOGY (2021)

Add to Collection

Article Clinical Neurology

Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C

Allegra Kawles, Yasushi Nishihira, Alex Feldman, Nathan Gill, Grace Minogue, Rachel Keszycki, Christina Coventry, Callen Spencer, Jaclyn Lilek, Kaouther Ajroud, Giovanni Coppola, Rosa Rademakers, Emily Rogalski, Sandra Weintraub, Hui Zhang, Margaret E. Flanagan, Eileen H. Bigio, M-Marsel Mesulam, Changiz Geula, Qinwen Mao, Tamar Gefen

Summary: This study provides a detailed characterization of the pathological distribution of TDP-43 and gliosis in FTLD-TDP-type C, and investigates the relationship between inclusions and neurodegeneration. The findings suggest an inverse relationship between the extent of TDP-positive inclusions and neuronal loss.

BRAIN (2022)

Add to Collection

Editorial Material Cell Biology

Propagation of TDP-43 proteinopathy in neurodegenerative disorders

Rachel Keszycki, Pouya Jamshidi, Allegra Kawles, Grace Minogue, Margaret E. Flanagan, Colleen R. Zaccard, M-Marsel Mesulam, Tamar Gefen, Changiz Geula

NEURAL REGENERATION RESEARCH (2022)

Add to Collection

Article Neurosciences

Integrity of Neuronal Size in the Entorhinal Cortex Is a Biological Substrate of Exceptional Cognitive Aging

Caren Nassif, Allegra Kawles, Ivan Ayala, Grace Minogue, Nathan P. Gill, Robert A. Shepard, Antonia Zouridakis, Rachel Keszycki, Hui Zhang, Qinwen Mao, Margaret E. Flanagan, Eileen H. Bigio, M. -Marsel Mesulam, Emily Rogalski, Changiz Geula, Tamar Gefen

Summary: This study found that the neuronal integrity in the entorhinal cortex (ERC) differentiated SuperAgers from normal elderly peers, indicating that ERC integrity is a biological substrate of exceptional memory in old age.

JOURNAL OF NEUROSCIENCE (2022)

Add to Collection

Article Neurosciences

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Jaclyn Lilek, Kaouther Ajroud, Alexander Z. Feldman, Sesha Krishnamachari, Shadi Ghourchian, Tamar Gefen, Callen L. Spencer, Allegra Kawles, Qinwen Mao, Jessica F. Tranovich, Clifford R. Jack, M-Marsel Mesulam, R. Ross Reichard, Hui Zhang, Melissa E. Murray, David Knopman, Dennis W. Dickson, Ronald C. Petersen, Benjamin Smith, Karen H. Ashe, Michelle M. Mielke, Kathryn M. Nelson, Margaret E. Flanagan

Summary: Phosphorylated cytoplasmic tau inclusions are correlated with and precede cognitive deficits in Alzheimer's Disease (AD). The results also indicate that the frontal cortex represents early AD, while entorhinal total tau levels are significantly higher in amnestic mild cognitive impairment compared to AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Add to Collection

Article Neurosciences

Differential vulnerability of the dentate gyrus to tauopathies in dementias

Allegra Kawles, Grace Minogue, Antonia Zouridakis, Rachel Keszycki, Nathan Gill, Caren Nassif, Christina Coventry, Hui Zhang, Emily Rogalski, Margaret E. E. Flanagan, Rudolph Castellani, Eileen H. H. Bigio, M. Marsel Mesulam, Changiz Geula, Tamar Gefen

Summary: The dentate gyrus (DG) in the hippocampus shows varying vulnerability to pathological tau accumulation in different tauopathies, suggesting different susceptibilities and raising questions about the integrity and functional significance of hippocampal circuits in neurodegenerative dementias.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Add to Collection

Article Geriatrics & Gerontology

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies

Rachel Keszycki, Allegra Kawles, Grace Minogue, Antonia Zouridakis, Alyssa Macomber, Nathan Gill, My Vu, Hui Zhang, Christina Coventry, Emily Rogalski, Sandra Weintraub, M-Marsel Mesulam, Changiz Geula, Tamar Gefen

Summary: Frontotemporal lobar degeneration (FTLD) with tau pathology (FTLD-tau) commonly causes dementia syndromes, characterized by primary progressive aphasia (PPA) and behavioral variant frontotemporal dementia (bvFTD). This study examines the neuropsychiatric symptoms of participants with PPA or bvFTD due to autopsy-confirmed FTLD-tau, and investigates whether certain symptoms can predict specific FTLD-tauopathies.

FRONTIERS IN AGING NEUROSCIENCE (2023)

Add to Collection

Article Clinical Neurology

Distinct Patterns of Hippocampal Pathology in Alzheimer & apos;s Disease with Transactive Response DNA-binding Protein?43

Grace Minogue, Allegra Kawles, Antonia Zouridakis, Rachel Keszycki, Alyssa Macomber, Vivienne Lubbat, Nathan Gill, Qinwen Mao, Margaret E. Flanagan, Hui Zhang, Rudolph Castellani, Eileen H. Bigio, M. -Marsel Mesulam, Changiz Geula, Tamar Gefen

Summary: This study investigates the neuronal integrity and pathological burden of TDP-43 and tau in patients with AD/TDP, AD alone, or FTLD-TDP. The findings suggest that TDP-43 and tau immunoreactivity is highest in the DG of AD/TDP. Furthermore, tau aggregation in AD/TDP may be enhanced by TDP-43.

ANNALS OF NEUROLOGY (2023)

Add to Collection

Article Neurosciences

Shades of gray in human white matter

Antonia Zouridakis, Ivan Ayala, Grace Minogue, Allegra Kawles, Rachel Keszycki, Alyssa Macomber, Eileen H. Bigio, Changiz Geula, Marek-Marsel Mesulam, Tamar Gefen

Summary: Anatomists have conducted a study on neurons in the white matter, which is not supposed to contain neurons. The study investigated 15 postmortem human specimens and found two distinct populations of neurons, one derived from subplate neurons and the other embedded in deep white matter. These neurons showed heterogeneous neurochemical properties and were positive for various markers, including acetylcholinesterase and neuronal nuclei.

JOURNAL OF COMPARATIVE NEUROLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.